Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer.
Zheng B, Liang L, Wang C, Huang S, Cao X, Zha R, Liu L, Jia D, Tian Q, Wu J, Ye Y, Wang Q, Long Z, Zhou Y, Du C, He X, Shi Y.
Clin Cancer Res. 2011 Dec 15;17(24):7574-83. Epub 2011 Oct 12.
Related citations
Gastric cancer growth control by BEZ235 in vivo does not correlate with PI3K/mTOR target inhibition but with [18F]FLT uptake.
Fuereder T, Wanek T, Pflegerl P, Jaeger-Lansky A, Hoeflmayer D, Strommer S, Kuntner C, Wrba F, Werzowa J, Hejna M, Müller M, Langer O, Wacheck V.
Clin Cancer Res. 2011 Aug 15;17(16):5322-32. doi: 10.1158/1078-0432.CCR-10-1659. Epub 2011 Jun 28.
Pertuzumab in combination with trastuzumab shows significantly enhanced antitumor activity in HER2-positive human gastric cancer xenograft models.
Yamashita-Kashima Y, Iijima S, Yorozu K, Furugaki K, Kurasawa M, Ohta M, Fujimoto-Ouchi K.
Clin Cancer Res. 2011 Aug 1;17(15):5060-70. Epub 2011 Jun 23.
Clinical significance of miR-146a in gastric cancer cases.
Kogo R, Mimori K, Tanaka F, Komune S, Mori M.
Clin Cancer Res. 2011 Jul 1;17(13):4277-84. Epub 2011 Jun 1.
The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer.
Yasumoto K, Yamada T, Kawashima A, Wang W, Li Q, Donev IS, Tacheuchi S, Mouri H, Yamashita K, Ohtsubo K, Yano S.
Clin Cancer Res. 2011 Jun 1;17(11):3619-30. Epub 2011 Apr 11.
CpG blocks immunosuppression by myeloid-derived suppressor cells in tumor-bearing mice.
Zoglmeier C, Bauer H, Nörenberg D, Wedekind G, Bittner P, Sandholzer N, Rapp M, Anz D, Endres S, Bourquin C.
Clin Cancer Res. 2011 Apr 1;17(7):1765-75. Epub 2011 Jan 13.
Gene expression signature-based prognostic risk score in gastric cancer.
Cho JY, Lim JY, Cheong JH, Park YY, Yoon SL, Kim SM, Kim SB, Kim H, Hong SW, Park YN, Noh SH, Park ES, Chu IS, Hong WK, Ajani JA, Lee JS.
Clin Cancer Res. 2011 Apr 1;17(7):1850-7. Epub 2011 Mar 29.
Molecular classification of gastric cancer: a new paradigm.
Shah MA, Khanin R, Tang L, Janjigian YY, Klimstra DS, Gerdes H, Kelsen DP.
Clin Cancer Res. 2011 May 1;17(9):2693-701. Epub 2011 Mar 23.
Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer.
Oh HK, Tan AL, Das K, Ooi CH, Deng NT, Tan IB, Beillard E, Lee J, Ramnarayanan K, Rha SY, Palanisamy N, Voorhoeve PM, Tan P.
Clin Cancer Res. 2011 May 1;17(9):2657-67. Epub 2011 Mar 17.
Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis.
Kang W, Tong JH, Chan AW, Lee TL, Lung RW, Leung PP, So KK, Wu K, Fan D, Yu J, Sung JJ, To KF.
Clin Cancer Res. 2011 Apr 15;17(8):2130-9. Epub 2011 Feb 23.
ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis.
Yin M, Yan J, Martinez-Balibrea E, Graziano F, Lenz HJ, Kim HJ, Robert J, Im SA, Wang WS, Etienne-Grimaldi MC, Wei Q.
Clin Cancer Res. 2011 Mar 15;17(6):1632-40. Epub 2011 Jan 28. Review.
MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab.
Nishida N, Mimori K, Fabbri M, Yokobori T, Sudo T, Tanaka F, Shibata K, Ishii H, Doki Y, Mori M.
Clin Cancer Res. 2011 May 1;17(9):2725-33. Epub 2011 Jan 10.
Monoclonal antibodies to fibroblast growth factor receptor 2 effectively inhibit growth of gastric tumor xenografts.
Zhao WM, Wang L, Park H, Chhim S, Tanphanich M, Yashiro M, Kim KJ.
Clin Cancer Res. 2010 Dec 1;16(23):5750-8. Epub 2010 Jul 29.
Inhibition of Src impairs the growth of met-addicted gastric tumors.
Bertotti A, Bracco C, Girolami F, Torti D, Gastaldi S, Galimi F, Medico E, Elvin P, Comoglio PM, Trusolino L.
Clin Cancer Res. 2010 Aug 1;16(15):3933-43. Epub 2010 Jul 13.
Overexpression of p73 as a tissue marker for high-risk gastritis.
Carrasco G, Diaz J, Valbuena JR, Ibanez P, Rodriguez P, Araya G, Rodriguez C, Torres J, Duarte I, Aravena E, Mena F, Barrientos C, Corvalan AH.
Clin Cancer Res. 2010 Jun 15;16(12):3253-9. Epub 2010 Jun 8.
Modulation of lymphocyte regulation for cancer therapy: a phase II trial of tremelimumab in advanced gastric and esophageal adenocarcinoma.
Ralph C, Elkord E, Burt DJ, O'Dwyer JF, Austin EB, Stern PL, Hawkins RE, Thistlethwaite FC.
Clin Cancer Res. 2010 Mar 1;16(5):1662-72. Epub 2010 Feb 23.
Lapatinib, a dual EGFR and HER2 kinase inhibitor, selectively inhibits HER2-amplified human gastric cancer cells and is synergistic with trastuzumab in vitro and in vivo.
Wainberg ZA, Anghel A, Desai AJ, Ayala R, Luo T, Safran B, Fejzo MS, Hecht JR, Slamon DJ, Finn RS.
Clin Cancer Res. 2010 Mar 1;16(5):1509-19. Epub 2010 Feb 23.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on